EFFICIENCY OF THE NEW MEDICATION OF FS-1 IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS

In vitro studies have proved the anti-tuberculosis eect of FS-1 medication both against susceptible strain of M. tuberculosis H37Rv, and the strain of M. tuberculosis MS-115 with multiple drug resistance.Conducted in vivo studies on guinea pigs infected with the pathogenic culture of human tuberculo...

Full description

Saved in:
Bibliographic Details
Published inTuberkulëz i bolezni lëgkikh no. 12; pp. 50 - 56
Main Authors M. E. Kulmanov, B. F. Kerimzhanova, L. N. Chernousova, I. V. Bocharova, L. N. Lepekha, A. I. Il'in
Format Journal Article
LanguageRussian
Published New Terra Publishing House 01.12.2015
Subjects
лекарственное средство фс-1
противотуберкулезная активность
экспериментальный туберкулез
Online AccessGet full text

Cover

More Information
Summary:In vitro studies have proved the anti-tuberculosis eect of FS-1 medication both against susceptible strain of M. tuberculosis H37Rv, and the strain of M. tuberculosis MS-115 with multiple drug resistance.Conducted in vivo studies on guinea pigs infected with the pathogenic culture of human tuberculosis (strain of H37Rv), have shown that FS-1 provides expressed anti-inflammatory action on the course of experimental tuberculosis.
ISSN:2075-1230
2542-1506